Guidance for Treating Patients with Opioid Use Disorder (OUD) with Buprenorphine- Naloxone (B/N) in the COVID-19 Era via Telehealth: A Review of Previous Evidence, New COVID-19 OUD Treatment Guidelines, and a Case Report of their Application
Show full item record

This item appears in the following Collection(s)


Search Deep Blue

Advanced Search

Browse by

My Account

Information

Available Now


MLibrary logo